NRx Pharmaceuticals, Inc.
NASDAQNRXP short interest surges 32% in one week to 15.8% of float, driven by clinical-stage biotech volatility and mounting short pressure on the small-cap pharma name.
Snapshot as of 23 Jun 2026
NRx Pharmaceuticals heads into its May 18 earnings call with short sellers aggressively rebuilding positions and the stock simultaneously pushing higher — a tension that makes this week's setup unusually charged. Short…
NRx Pharmaceuticals heads into its May 18 earnings with short sellers making one of their most aggressive moves in the stock all year. Short interest is the story here. Bears have nearly doubled their position in a…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NRXP — free to start on ORTEX.
Sign up for free →Open NRXP on ORTEX